INTRODUCTION {#S1}
============

Classically considered a part of the innate system, natural killer (NK) cells represent a heterogeneous cell population integrating activating and inhibiting receptors to mediate killing and cytokine-based modulation of tumor and virus-infected cells. One major contribution of the NK cell repertoire is serving as the effector cell against targets bound by antibody in antibody-dependent cell-mediated cytotoxicity (ADCC). During HIV and simian immunodeficiency virus (SIV) infections, NK cells contribute to the control of virus replication and disease progression through multiple mechanisms and specifically elicit robust ADCC responses ([@R3]; [@R2]; [@R6]; [@R9]; [@R10]; [@R17]; [@R32]; [@R36]; [@R49]). Indeed, ADCC has been implicated in superior antiviral activities in HIV-1 "elite controllers" ([@R20]; [@R52]) and may have contributed to protective effects elicited by non-neutralizing antibodies in the RV144 Thai trial ([@R16]).

Immune experience significantly influences diversity in the NK cell receptor repertoire ([@R43]), and although few viruses are known to infect NK cells directly, viral infections can drive diversification, activation, and dysfunction of NK cells *in vivo* ([@R7]; [@R26]). CMV infection tunes NK cell education and expansion of specific NK cell subsets ([@R5]), and some of the first characterizations of adaptive NK cells were found in murine CMV infection, with analogous adaptive expansion found in human cytomegalovirus (HCMV) ([@R8]; [@R15]; [@R18]; [@R25]; [@R38]; [@R44]). Multiple studies confirmed that murine NK cells mediate recall against non-CMV antigens ([@R14]; [@R27]; [@R30]; Paust et al., 2009), and memory NK cell responses subsequently have been demonstrated against multiple pathogens in mice and humans ([@R34]). Evidence of memory NK cells was shown in rhesus macaques by our laboratory ([@R37]). In addition to the description of antigen-specific NK cells, recent evidence has also identified a subpopulation of memory-like or adaptive NK cells that are exquisite effector cells when granted specificity through antibody binding. These cells first described in humans in 2012 by Zhang et al. ([@R19]) express high levels of FcγR (including CD16) but lack the γ-signaling chain. So-called g-- or Δg NK cells are found at low frequencies in all individuals but expand in CMV-seropositive persons. Following initial antibody binding, these cells may be epigenetically modified but become long-lived and capable of recall-like responses ([@R22]; [@R41]). Recently, Δg NK cells have been shown to be increased 7-fold in HIV-infected persons and are associated with enhanced ADCC against HIV antigens ([@R53]). Although these γ-chain deficient, Syk-deficient NK cells have been reported in humans, such an observation has not been made in any effector sites or in macaques or mice, leaving a critical animal model lacking for the study of these cells. Most importantly, the mechanisms that promote enhanced adaptive function by Δg and other memory and adaptive NK cell populations, as well as the role of CMV in this innate priming, remain largely unexplored.

RESULTS {#S2}
=======

Δg NK Cells Comprise a Distinct Subset of Primate NK Cells {#S3}
----------------------------------------------------------

We first identified a distinct circulating population of Syk^lo^ γ-chain^−/lo^ NK cells in rhesus cytomegalovirus (rhCMV)-positive macaques ([Figure 1A](#F1){ref-type="fig"}) among standardly defined macaque CD3^−^CD14^−^CD20^−^HLA-DR^dim^ NKG2A/C+ NK cells ([@R36]; [@R42]; [@R45]) and confirmed co-expression of other NK cell-related markers, such as NKp46 and CD8α ([Figure 1B](#F1){ref-type="fig"}; [Figures S1A and S1B](#SD1){ref-type="supplementary-material"}). Δg NK cells expressed reduced levels of the inhibitory receptor Siglec-7 ([Figure S1C](#SD1){ref-type="supplementary-material"}), suggesting a more basal activation state, and also had downregulated expression of the NK cell transcription factors Helios and Eomes compared with conventional NK (cNK) cells ([Figure 1B](#F1){ref-type="fig"}; [Figures S1D and S1E](#SD1){ref-type="supplementary-material"}), likely indicative of a disparate developmental program or epigenetic modification ([@R22]). Δg NK cells had a higher frequency of CD16+ subpopulations ([Figure 1C](#F1){ref-type="fig"}; [Figure S1F](#SD1){ref-type="supplementary-material"}), higher Fas (CD95) expression ([Figures S2A and S2B](#SD1){ref-type="supplementary-material"}), and increased cytotoxic arming with Granzyme B than the cNK cells ([Figures S2C and S2D](#SD1){ref-type="supplementary-material"}). Multidimensional t-distributed stochastic neighbor embedding (*t*-SNE) analyses of flow cytometric markers confirmed that although, as expected, there is significant phenotypic overlap with cNK, Δg NK cells segregate and are distinct ([Figure 1D](#F1){ref-type="fig"}; [Figure S3](#SD1){ref-type="supplementary-material"}). Principal-component analysis (PCA) revealed a similar disparate relationship between Δg and cNK cells, most heavily influenced by γ-chain and Syk ([Figure 1E](#F1){ref-type="fig"}). Collectively, these data confirmed the identification of a highly distinct functionally robust and transcriptionally modified Δg NK cell population.

rhCMV Expands and Primes Adaptive Δg NK Cells {#S4}
---------------------------------------------

Initial observations have suggested that the expansion of Δg and other memory and adaptive NK cells is linked to CMV infection ([@R22]; [@R44]). To validate these findings, we quantified Δg NK cells in cohorts of rhCMV-uninfected and rhCMV-infected rhesus macaques. Frequencies of Δg among total NK cells were significantly higher than cNK cells (medians, 8.5% and 17.4%, CMV− and CMV+, respectively) ([Figure 2A](#F2){ref-type="fig"}), but most striking was the one-log expansion in absolute Δg NK cells in circulation ([Figure 2B](#F2){ref-type="fig"}). Δg NK cells from rhCMV-infected animals also had significantly reduced Helios and upregulated CD16 expression ([Figures 2C and 2D](#F2){ref-type="fig"}), suggesting that not only does rhCMV induce an expansion of the adaptive Δg NK cell population but also regulates transcriptional and phenotypic changes. Indeed, Δg NK cells from rhCMV-uninfected and rhCMV-infected macaques clustered completely independently by *t*-SNE ([Figure 2E](#F2){ref-type="fig"}) and, importantly, were tightly associated with rhCMV-specific immunoglobulin G (IgG) levels as a surrogate indicator of virus replication ([Figure 2F](#F2){ref-type="fig"}). The disparate CD16 expression ([Figure 2](#F2){ref-type="fig"}; [Figure S1F](#SD1){ref-type="supplementary-material"}) also suggests these cells may have enhanced antibody binding and thereby improve functional recognition.

Δg NK Cells Are Found Systemically but Have Disparate Tissue-Homing Patterns {#S5}
----------------------------------------------------------------------------

Previous evaluations of adaptive NK cells have focused exclusively on characterizing these cells in human blood or culture systems, leaving a significant deficit as to whether or not this population could exist in meaningful effector sites. To address this deficit, we quantified Δg NK cells in multiple tissues and found them systemically distributed among spleen, bone marrow, multiple lymph node sites, and colonic mucosae ([Figure 3A](#F3){ref-type="fig"}; [Figure S6](#SD1){ref-type="supplementary-material"}). Although found systemically, Δg NK cells were notably more enriched (Mann-Whitney U, p = 0.02) in colonic tissue NK cells (median, 8.1%; range, 4.4 to 11.9%) than lymph node NK cells (median, 4.3%; range, 1.6 to 7.6%) from normal rhCMV-infected animals ([Figure S6](#SD1){ref-type="supplementary-material"}). Differences in homing properties between circulating Δg and cNK cells helped to clarify this distribution ([Figure 3B](#F3){ref-type="fig"}). Both CCR7 and CD62L, lymph node homing markers, were downregulated in Δg NK cells, whereas gut-homing α4β7 was 100% increased in circulating Δg cells compared with matched cNK cells ([Figures 3C--3E](#F3){ref-type="fig"}). Notably, these homing properties were not different when stratified by rhCMV status and, thus, may not be part of the NK cell repertoire that is impacted by CMV priming. We also analyzed whether these same differences were observed in tissue-resident NK cells and indeed found that Δg NK cells exhibited lower CCR7 and CD62L than their cNK cell counterparts in lymph nodes ([Figures 3F and 3G](#F3){ref-type="fig"}). Furthermore, α4β7 was significantly upregulated in Δg NK cells in colonic tissue ([Figure 3H](#F3){ref-type="fig"}), suggesting that these cells not only may preferentially home to the mucosae but also may be retained there. Altogether, these data demonstrate the systemic distribution of Δg NK cells but indicate that this NK cell population may preferentially survey effector sites, such as the gut, and not traffic through lymph nodes at the same frequency as cNK cells.

SIV Infection Systemically Expands Δg NK Cells and Induces Mucosal Homing {#S6}
-------------------------------------------------------------------------

Although CMV is a primary factor in the expansion and priming of Δg NK cells, the impact of other viruses remains poorly explored. In a large cohort of rhCMV-infected macaques that were experimentally challenged and chronically infected with SIVmac251 or SHIV162p3, we found slight but not statistically significant increases in frequencies and numbers of Δg NK cells in circulation compared with rhCMV-infected/SIVmac251/SHIV162p3-naive animals (Figures [2A, 2B](#F2){ref-type="fig"}, [4A, and 4B](#F4){ref-type="fig"}). Despite little change in blood, significant 2- to 5-fold increases of Δg NK cells were found in the colon, lymph nodes, and spleen, indicating that SIVmac251/SHIV162p3 infection may preferentially induce expansion at effector sites ([Figure 4C](#F4){ref-type="fig"}). Δg NK cell numbers are closely associated with rhCMV-specific IgG levels ([Figure 4E](#F4){ref-type="fig"}) rather than SIV viral loads ([Figure 4F](#F4){ref-type="fig"}), suggesting that numerical expansion is likely caused by increased rhCMV replication, a known phenomenon in HIV and SIV infections ([@R13]), whereas mucosal redistribution may be due to SIV infection. Indeed, the most robust increase was found in the colonic tissue of SIVmac251/SHIV162p3-infected macaques, and gut-homing α4β7, already preferentially expressed on Δg NK cells, is further significantly upregulated in circulating cells ([Figure 4D](#F4){ref-type="fig"}). Collectively, these data demonstrate that rhCMV-primed Δg NK cells are modified by SIV infection to home to mucosal and effector tissues.

Δg NK Cell Function Requires rhCMV Priming but Is Dysregulated in SIV Infection {#S7}
-------------------------------------------------------------------------------

Δg NK cells may have disparate functional profiles from cNK cells and have previously been shown to have recall-like capabilities ([@R22]). Our data indicated that Δg NK cells have increased cytotoxic arming ([Figure S2](#SD1){ref-type="supplementary-material"}), and here, we tested the impact of rhCMV infection in rhesus macaques on not only cytotoxic function but also cytokine production by using a modified ADCC assay ([Figure 5](#F5){ref-type="fig"}). Not surprisingly, Δg NK cells had similar upregulation of CD107a (as a surrogate marker for cytotoxicity) and tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), and macrophage inflammatory protein 1 beta (MIP-1β) production compared with cNK cells in rhCMV-infected animals. However, in rhCMV-uninfected macaques, Δg NK cells were almost completely non-responsive to antibody-target cell stimulation. These data confirmed and expanded previous observations that although cNK cells are functionally competent irrespective of CMV serostatus, Δg NK cells require CMV infection not only for numerical expansion but also to gain function.

We next evaluated the effects of chronic SIV infection on both cNK and Δg NK cells.

Other than CD107a, cNK cells had reduced functional capacity for all functions compared with rhCMV-infected/SIV-naive animals. Δg NK cells had even further suppressed functions, indicating that all NK cells show signs of ADCC dysfunction in SIV infection, this population may be disproportionately impacted.

Δg NK Cells Use Alternative Signaling Induced by rhCMV Priming {#S8}
--------------------------------------------------------------

The dramatic differences in CMV-driven function between Δg and cNK cells have been previously attributed, at least in part, to epigenetic modification ([@R22]). However, no clear mechanistic explanation has been elucidated for these and other types of memory and adaptive NK cells. Furthermore, because Δg NK cells lack the traditional γ-chain/Syk signaling, enhanced function in this cell population is counter-intuitive, and we hypothesized that Δg NK cells might switch to an alternative signaling pathway not typically used by CD16 binding. Indeed, we found that in lieu of the γ-chain ([Figure 1](#F1){ref-type="fig"}), Δg NK cells had up-regulated expression of CD3ζ and its adaptor molecule ZAP70, which can also alternatively mediate CD16-dependent signaling, as well as DAP12, all primed by rhCMV status ([Figures 6A--6C](#F6){ref-type="fig"}). Next, we evaluated levels of active signaling of these pathways, as measured by phosphorylation on activation sites. Not surprisingly, we confirmed that cNK cells, regardless of CMV status, use the Syk pathway, as indicated by activated pSyk, whereas Δg NK cells do not ([Figures S4A and S4B](#SD1){ref-type="supplementary-material"}). Phosphorylation of CD3ζ was greatest in rhCMV-infected animals overall, indicating it can be used by any NK cell, but was only present in Δg NK cells after rhCMV infection ([Figures 6D and 6E](#F6){ref-type="fig"}). Furthermore, we found that phosphorylation of the CD3ζ adaptor Zap70 is significantly greater in Δg than cNK cells ([Figures S5A and S5B](#SD1){ref-type="supplementary-material"}). These data demonstrate that adaptive Δg NK cell function relies at least partly on CD3ζ-Zap70 signaling but is also tightly coupled to previous rhCMV infection.

In identical assays, SIV-infected animals (as well as rhCMV-infected animals) showed evidence of extremely dysregulated signaling pathways. Expression patterns of CD3ζ were similar, but ZAP70 and DAP12 were downregulated ([Figures 6B and 6C](#F6){ref-type="fig"}). Even in cNK cells, the levels of Syk phosphorylation (the traditional pathway for these cells) were dramatically lower in SIV-infected animals than both rhCMV-uninfected and rhCMV-infected samples ([Figures S4A and S4B](#SD1){ref-type="supplementary-material"}), but most notably for Δg NK cells, alternative CD3ζ phosphorylation was near the limit of detection ([Figure 6E](#F6){ref-type="fig"}). Taken together with the fact that phenotypically Δg NK cells cluster completely independently in SIV-infected and SIV-naive animals, these data may explain the well-described dysfunction of NK cells in HIV and SIV infections ([Figure 5](#F5){ref-type="fig"}) ([@R1]; [@R36]) and indicate an active suppression of the adaptive Δg NK cells.

DISCUSSION {#S9}
==========

The studies herein provide some of the most robust insights into the combinatorial mechanisms of innate priming that explain the functional potency of Fc receptor (FcR)-bearing Δg adaptive NK cells. Specifically, our data elaborate on two phenomena: (1) Δg NK cells are rare and non-functional prior to CMV exposure but after CMV priming, expand numerically, functionally, and become active due to an alternative signaling switch to the CD3ζ-Zap70 pathway; and (2) dysfunction of CD16-mediated signaling in both cNK and Δg NK cells occurs in lentivirus infection and can be explained by abrogation of both γ-chain/Syk and CD3ζ-Zap70 signaling.

Although Δg NK cells have been described in human subjects ([@R22]), the fully functional niche, as well as distribution in tissues and species, has remained unclear. Others and we have now shown that Δg NK cells can produce cytokines as well as be simultaneously cytotoxic, and previous research indicates that epigenetic modification following antibody-antigen exposure drives more robust functionality ([@R22]). However, the differences we observed in the transcriptional regulation and the specific expansion of Δg cells but not cNK cells in rhCMV-infected animals suggests they could also represent an independent lineage of NK cells, as has been previously suggested for other memory NK cell subpopulations ([@R34]). Regardless, both numerical and functional expansions depend on rhCMV priming, as Δg NK cells were essentially non-functional in rhCMV-uninfected subjects (Figures [2](#F2){ref-type="fig"} and [5](#F5){ref-type="fig"}). Indeed, rhCMV status induced multifunctional responses, but also, the upregulation of Granzyme B and Fas are further indicative of an active priming of multiple cytotoxic mechanisms. rhCMV also induced a downregulation of inhibitory molecules, such as Siglec-7, but an upregulation of CD16. FcR like CD16 are typically recycled relatively quickly on the surface of NK cells by a series of enzymes, including ADAM17 (TACE), the inhibition of which has shown promise as an anti-tumor therapy ([@R39]). Future studies will need to determine if this type of mechanism could be specifically inhibited by CMV or is less active in Δg NK cells, but also further emphasizes that increased FcR stability and reduced inhibitory molecule expression promote enhanced functional activity. Another unexpected feature of Δg NK cells was the reduced expression of lymph node-homing molecules in lieu of the upregulation of gut-homing α4β7. Retinoic acid is a primary regulator of cell surface α4β7 expression ([@R28]) and has a reciprocal relationship with CMV ([@R12]), so increased expression may be a direct consequence of ongoing rhCMV replication. Regardless, this altered expression pattern could explain, at least in part, the enrichment of these cells in the mucosae and suggests they may have a more active role in surveillance of effector sites.

One component of our study was to address the effects of lentivirus infection on systemic numbers and functions of Δg NK cells and in an animal model. A recent study indicated that Δg NK cells expand numerically in HIV infection ([@R53]), but our observations further clarify that this is most likely associated with rhCMV replication rather than HIV or SIV. However, we did find that in chronic SIV infection, Δg NK cells upregulated α4β7 and increased homing to colonic tissue and other effector sites ([Figure 4](#F4){ref-type="fig"}). Perturbed retinoid metabolism in infection ([@R24]) is a putative source of increased imprinting of α4β7 on Δg NK cell mucosal homing, and we and others have previously found this may be a generalized NK cell phenomenon in SIV infection ([@R35]). Consistent with previous observations for cNK cells in HIV infection ([@R1]), SIV also caused a significant dysregulation of Δg NK cell functionality that could be due to anergy and exhaustion ([@R40]), but, as discussed below, this is most likely due to dysregulated signaling. Collectively, data from our study and others indicate that HIV and SIV may not influence the expansion or priming of the Δg NK cell population per se but can indirectly have major impacts on trafficking and function.

Another important observation in our study is that Δg NK cells in rhesus macaques, and similarly in humans ([@R23]), do not use the γ-chain/Syk CD16 signaling pathway but rather use CD3ζ/Zap70 signaling and only after CMV priming. Although the need for CD16 to signal through γ-chain or CD3ζ molecules is well established, whether the recruitment of either molecule is inherent to a specific downstream function is less clear ([@R21]; [@R31]; [@R48]; [@R51]). Homodimers of γ-chain are preferentially expressed in NK cells and cytotoxic T cells, suggesting that this is the preferential arrangement for cytotoxic functions, particularly in mice, but heterodimers of CD3ζ and γ-chain may be the more common pathway for ADCC in humans ([@R46]; [@R47]). This concept is clearly reflected in our data whereby cNK cells assemble the γ-chain/Syk complex but also express comparable levels of CD3ζ, suggesting that macaque cNK cells are likely using a heterodimeric complex. However, in Δg NK cells, a CMV-associated lack of γ-chain leads to a less common CD3ζ homodimeric-ZAP70 complex to induce much more robust FcR-mediated effector responses ([Figure 5](#F5){ref-type="fig"}). These data highlight the underappreciated signaling heterogeneity that may occur in memory and adaptive NK cell subsets, and the overall lack of CD3ζ signaling may explain, in part, why Δg NK cells do not appear to exist in mice, further underscoring the need for an animal model, such as rhesus macaques. Beyond rhCMV-priming of Δg NK cells, the most dramatic signaling changes were observed in SIV-infected animals ([Figure 6](#F6){ref-type="fig"}). Activation of both γ-chain and CD3ζ pathways were dramatically suppressed, which likely explains the functional dysregulation of both Δg and cNK cells in HIV and SIV infections ([Figure 5](#F5){ref-type="fig"})([@R1]). These data also raise the alternative hypothesis that other molecules and signaling pathways may be recruited in NK cells during HIV and SIV infection or that a different immunoreceptor tyrosine-based activation motif (ITAM) of CD3ζ (other than the typical third ITAM, Y142) may be phosphorylated. However, the fact that DAP12, associated with NKG2D signaling ([@R11]), is also downregulated in SIV infection ([Figure 5](#F5){ref-type="fig"}) suggests this is a global suppression of active NK cell signaling and will need significant additional studies to elucidate the full mechanisms. Overall, our data indicate that Δg NK cells recruit specific signaling machinery as part of an alternative repertoire to mount a robust virus-tuned response but can be actively inhibited by lentivirus infection.

Altogether, we present herein a demonstration of adaptive Δg NK cells in tissues, delineate a primary mechanism of functional potency, explain in part NK cell functional dysregulation in SIV infection, and importantly solidify a tangible animal model to study this cell population. The functional potency of Δg NK cells indicates they could be very attractive targets for antibody-based therapeutics and vaccine modalities against HIV and other pathogens. Further research will be needed to evaluate the protective efficacy of these responses and if they could be experimentally modulated or expanded outside of natural rhCMV infection or restored in SIV infection.

STAR★METHODS {#S10}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S11}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, R. Keith Reeves (<rreeves@bidmc.harvard.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S12}
--------------------------------------

### Macaques {#S13}

A total of seventy male and female Indian origin rhesus macaques (*Macaca mulatta*) were used in various components of this study: 28 specific pathogen-free rhCMV-uninfected (\< 1 mg/ml anti-rhCMV IgG); 14 rhCMV-infected but otherwise experimentally naive; 8 chronically infected with SHIVsf162p3, and 20 chronically SIVmac239/251-infected macaques. All animals were randomized to infection groups without specific exclusion and technical staff were blinded to groupings at the time of analyses. All groups contained comparable numbers of males and females and no significant differences in the data were observed based on gender, and ranged in age from 1.7 to 11.6 years at the time of study. All animals were healthy based on veterinary examination, and SIV and SHIV-infected macaques were exhibiting clinical signs of AIDS at the time of analysis. Animals were cared for according to the guidelines of the local Institutional Animal Care and Use Committee (IACUC). Animals were euthanized in order to collect tissues for analyses.

METHOD DETAILS {#S14}
--------------

### rhCMV antibody titers and SIV viral loads {#S15}

Total rhCMV-specific IgG levels were measured in cell free plasma ([@R29]), and SIV viral loads were measured by RT-PCR with RNA purified by the phenol-chloroform technique. Viral RNA was isolated from plasma using RNA extraction kit (QIAGEN, Germantown, MD) and manufacturer's protocol was followed. Quantified RNA was used for RT-PCR against a conserved region of *gag* using gene-specific primers ([@R50]). In the first step, RNA was reverse-transcribed followed by treatment with RNaseH for 20 min at 37°C. Next, cDNA was amplified using 7300 ABI Real-Time PCR system (applied Biosystems) according to the manufacturer's protocol.

### Blood and tissue collection and processing {#S16}

EDTA-treated venous blood was also collected at various time points and mononuclear cells were isolated using Ficoll-Paque^™^ (GE Healthcare, Waukesha, WI). Spleen, lymph nodes (LN), bulk bone marrow (BM) and colon were collected and mononuclear cells were isolated using procedures that have been previously described in our laboratory ([@R36]; [@R37]). Single-cell suspensions were prepared by mechanical disruption using syringe tops and 70 μm strainers (ThermoFisher Scientific, Waltham, DA). Suspended cells were either loaded on Percoll (colon) or Ficoll-Paque^™^ (blood, BM, liver spleen, and LN) solutions to separate cells using density-gradient centrifugation technique. Mononuclear cells were isolated from the interface of a 30%--60% discontinuous Percoll gradient or Ficoll-Paque^™^ according to manufacturers' suggested protocols. A hypotonic ammonium chloride solution (ACK, ThermoFisher Scientific, Waltham, DA) was used to lyse contaminating red blood cells. Cells were either immediately cultured or cryopreserved in freezing media (90% FBS, 10% DMSO) and stored in liquid nitrogen vapor. All procedures were conducted in a biosafety level 2 facility.

### Surface flow cytometry {#S17}

Fluorochrome-conjugated antibodies were purchased from BD Biosciences (San Jose, CA), ThermoFisher Scientific (Waltham, MA), Beckman-Coulter (Indianapolis, IN) and Cell Signaling Technology (Danvers, MA). Q-Prep (Beckman-Coulter) on PBMC was used for surface staining or intracellular staining. Antibodies used are listed in the [Key Resources Table](#T1){ref-type="table"}. Before antibody staining, cells were stained with Aqua Live/Dead stain (Invitrogen, Carlsbad, CA) for 30 minutes at room temperature in the dark followed by a wash step (PBS + 2% FBS). Data acquisitions were performed on an LSR II (BD Biosciences), and FlowJo software (version 9.9.4, Tree Star, Ashland, OR) was used for all analyses.

### Intracellular staining {#S18}

All intracellular staining was performed using Fix & Perm buffer kit (ThermoFisher Scientific, Waltham, MA). Briefly, cells were thawed at 37°C water bath and washed once before incubating for 6 hours at 37°C with PMA (0.05 μg/reaction) and Ionomycin (1 μg/reaction), followed by staining with surface antibodies. Then cells were fixed with Perm Buffer A followed by incubation with intracellular antibodies mixed with Perm Buffer B according to manufacturer's protocol. Cells were washed twice and fixed again with PFA before data acquisition.

### Phospho-flow {#S19}

BD Perm buffer III (BD Biosciences, La Jolla, CA) was used for phospho-flow analyses according to the manufacturers' protocols. Briefly, cells were opsonized with anti-human CD16 (BD Biosciences, clone 3G8, La Jolla, CA) followed by cross-linking with secondary goat-anti-mouse F(ab)'2, (Jackson ImmunoResearch Laboratories, West Grove, PA). Reactions were immediately stopped after 2.5 minutes (experimentally determined, data not shown) with equal volumes of Fix Buffer I (BD Biosciences, La Jolla, CA). After washing, unused/ unoccupied sites of the secondary antibody were blocked with normal mouse serum (ThermoFisher) for 10 minutes at room temperature. Fixation was followed by surface stain, permeabilization with Perm Buffer III for 30 minutes on ice, followed by intracellular staining at room temperature according to the manufacturer's protocol.

### Multiparametric analysis {#S20}

FCS files were imported into FlowJo v9.9.6 and manual gating analysis was used to select live NK cells as defined in [Figure 1](#F1){ref-type="fig"}. NK cell population data were exported and multiparametric analyses were performed using the Cyt program ([@R4]). Briefly, data were loaded into Cyt, transformed, concatenated and Barnes-Hut *t*-distributed stochastic neighboring embedding (bh-SNE) and Principal Component Analysis (PCA) were performed. Manual gating was used to overlay color on target populations.

### Antibody dependent cell cytotoxicity {#S21}

Isolated fresh or frozen PBMCs were rested overnight, counted and co-cultured for 6 hours at a 25:1 effector to target ratio with CEM.NKR target cells in the presence or absence of 10 μg/mL rhesusized anti-human CD4. Unbound rhesusized anti-human CD4 was removed from the culture media via wash steps prior to the co-culture. Anti-CD4 antibody concentrations and effector to target ratio were determined from prior titration experiments (data not shown). Brefeldin A, monensin, and CD107a, were added at the start of incubation. After incubation cells were stained for both surface and intracellular proteins using antibodies described above.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S22}
---------------------------------------

### Statistical analysis {#S23}

All statistical and graphic analyses were conducted with GraphPad Prism 7.0 software (GraphPad Software, La Jolla, CA). Nonparametric Mann-Whitney *U*-tests, Wilcoxon Matched Pairs test, Student's t tests, and Spearman's correlations were used where indicated, and a *P value* of \< 0.05 (by two-tailed test) was considered statistically significant. Nonparametric tests were used because data were determined not to be normally distributed as is anticipated for outbred animal studies.

DATA AND SOFTWARE AVALAIBILITY {#S24}
------------------------------

All data shown in Figures and Supplemental Figures show raw values and data points indicate individual animals. All data generated and analyzed in this study are available from the corresponding author upon reasonable request.
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![Identification of a Distinct Population of γ-chain/Syk-Deficient NK Cells in rhCMV+ Rhesus Macaques\
(A) Representative gating strategy identifying Δg among bulk NK cells.\
(B) Representative histograms showing expression of NKp46, CD8α, Siglec-7, Helios, and Eomes in Δg and cNK cells.\
(C) Representative flow cytometry plots indicating distribution of CD56^+^ and CD16^+^ subpopulations in Δg and cNK cells.\
(D and E) Composite phenotypic *t*-SNE plot (D) and PCA analysis (E) of bulk NK cells down-selected from rhCMV-infected rhesus macaque cohorts showing independent multidimensional clustering of Δg NK cells; data points represent individual cells.\
Individual parameters are shown in [Figure S3](#SD1){ref-type="supplementary-material"}. All plots are representative of 6 to 70 animals depending on grouping and measured parameter.](nihms-1516711-f0002){#F1}

![Δg NK Cells Are Primed by CMV Status\
(A--D) Frequencies among bulk NK cells (A) and normalized circulating numbers of Δg NK cells (B) are shown for rhCMV-uninfected (n = 28) and rhCMV-infected (n = 14) rhesus macaques. Horizontal lines indicate medians. Density of intracellular Helios (MFI, median fluorescence intensity) (C) and surface CD16 on Δg NK cells (D) in peripheral blood nuclear cells (PBMCs) from rhCMV-uninfected and rhCMV-infected macaques. Bars indicate medians.\
(E) Composite phenotypic *t*-SNE plot of Δg NK cells only down-selected in both rhCMV-uninfected and rhCMV-infected rhesus macaque cohorts showing near complete independent multidimensional clustering by rhCMV-specific IgG levels; data points represent individual cells.\
(F) Correlation of circulating Δg NK cell numbers with rhCMV-binding antibody equivalents.\
Statistical evaluations were made with Mann Whitney *U* or Spearman's correlation test; \*\*p \<0.01; \*\*\*p \< 0.001; \*\*\*\*p \< 0.0001.](nihms-1516711-f0003){#F2}

![Systemic Distribution and Mucosal-Homing of Δg NK Cells\
(A) Representative flow cytometry plots showing Δg NK cells in secondary lymphoid and colonic tissues.\
(B) Representative histograms showing CCR7, CD62L, and α4β7 expression on Δg and cNK cells in PBMC.\
(C--H) Median fluorescence intensities (MFI) of CCR7 (C), CD62L(D), and α4β7 (E) on Δg and cNK cells in PBMC from rhCMV-uninfected (n = 28, open circles) and rhCMV-infected (n = 14, closed circles) rhesus macaques. MFI of CCR7 (F) and CD62L (G) on LN resident NK cells, and α4β7 (H) on colonic NK cells. Horizontal lines indicate medians, and connecting lines are shown between individual animals.\
Statistical evaluations were made with Wilcoxon rank-sum test; \*p \< 0.05; \*\*p \< 0.01. MLN, mesenteric lymph node; PLN, peripheral lymph node; OLN, oral lymph nodes.](nihms-1516711-f0004){#F3}

![Mucosal-Homing Δg NK Cells Expand during SIVmac251/SHIV162p3 Infection\
(A) Frequencies among bulk NK cells in SIVmac251/SHIV162p3-infected rhesus macaques (n = 28). Horizontal bars indicate medians.\
(B) Frequencies among normalized circulating numbers of Δg NK cells in SIVmac251/SHIV162p3-infected rhesus macaques (n = 28). Horizontal bars indicate medians.\
(C) Frequencies of Δg NK cells among tissue mononuclear r cells in of SIV and SHIV-infected (also rhCMV-infected) and otherwise normal rhCMV-infected macaques. Bars indicate medians.\
(D) Density of surface α4β7 (MFI, median fluorescence intensity) on Δg NK cells in PBMC.\
(E and F) Correlations of Δg NK cell numbers with rhCMV-binding antibody equivalents (E) and SIVmac251/SHIV162p3 plasma virus loads (F).\
Statistical evaluations were made with Mann Whitney *U* or Spearman's correlation test; \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.](nihms-1516711-f0005){#F4}

![Functional Differences in cNK and Δg NK Cells in rhCMV-Uninfected, rhCMV-Infected, and SIVmac251/SHIV162p3-Infected Rhesus Macaques\
(A--D) Intracellular expression of CD107a (A) and production of TNF-α (B), MIP-1β (C), and IFN-γ (D) were measured by ADCC ICS as described in the [STAR Methods](#S10){ref-type="sec"}.\
Bars represent means ± SEM of 6--8 animal samples per group. Statistical comparisons between Δg and cNK cells were conducted using Student's paired t test; \*p \< 0.05; \*\*p \< 0.01.](nihms-1516711-f0006){#F5}

![cNK and Δg NK Cell Signaling in rhCMV-Uninfected, rhCMV-Infected, and SIVmac251/SHIV162p3-Infected Rhesus Macaques\
(A--C) Expression of signaling molecules involved in the CD16 signaling pathway were measured by intracellular and phosphor-flow cytometry. Relative expression of parent signaling molecules CD3ζ (A), ZAP70 (B), and DAP12 (C) in Δg NK cells relative to expression in cNK cells.\
(D) Representative plots from inactive and activated phosphoCD3ζ samples are shown. Δg and cNK cells were gated as shown in [Figure 1](#F1){ref-type="fig"}.\
(E) Frequencies of phosphorylated parent CD3ζ are shown as bars representing means ± SEM of 6--10 animal samples per group.\
Statistical comparisons between infection groups were conducted with the Mann-Whitney *U* test, and statistical comparisons between conditions for individual animals were conducted using Wilcoxon rank-sum test; \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \<0.001, \*\*\*\*p\<0.0001.](nihms-1516711-f0007){#F6}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                SOURCE                                      IDENTIFIER
  -------------------------------------------------- ------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------
  Antibodies (clone)                                                                             
  α4β7-APC (A4B7)                                    <http://nhpreagents.org/NHP/default.aspx>   Cat\# PR-1421
  CD3-BV786 (SP34.2)                                 3D Biosciences                              Cat\# 563918; RRID: AB_2738487
  CD8-BV650 (RPA-T8)                                 3D Biosciences                              Cat\# 563822; RRID: AB_2744462
  CD8-BV605 (SK1)                                    BD Biosciences                              Cat\# 564116; RRID: AB_2744466
  CD14-BUV395 (MϕP9)                                 BD Biosciences                              Cat\# 563561; RRID: AB_2744288
  CD16-BUV496 (3G8)                                  BD Biosciences                              Cat\# 564653; RRID: AB_2744294
  CD20-BUV395 (L27)                                  BD Biosciences                              Cat\# 740204; RRID: AB_2739954
  CD56-BV786 (NCAM16.2)                              BD Biosciences                              Cat\# 564058; RRID: AB_2738569
  CD62L-BV711 (SK11)                                 BD Biosciences                              Cat\# 565040; RRID: AB_2744438
  CD69-ECD (TP1.55.3)                                Beckman Coulter                             Cat\# 6607110; RRID: AB_1575978
  CD95/Fas-BUV737 (DX2)                              BD Biosciences                              Cat\# 564710; RRID: AB_2738907
  CD95/Fas-APC (DX2)                                 BD Biosciences                              Cat\# 558814; RRID: AB_398659
  CD107a/LAMP-1-PECF594 (H4A3)                       BD Biosciences                              Cat\# 562628; RRID: AB_2737686
  CD107a/LAMP-1-PE-Cy7 (H4A3)                        BD Biosciences                              Cat\# 561348; RRID: AB_10644018
  CD159a/NKG2a-APC (Z199)                            Beckman Coulter                             Cat\# A60797; RRID: AB_10643105
  CD159a/NKG2a-PC7 (Z199)                            Beckman Coulter                             Cat\# B10246; RRID: AB_2687887
  CD197/CCR7-BV421 (G043H7)                          BioLegend                                   Cat\# 353208; RRID: AB_11203894
  CD247/CD3ζ-FITC (H146-968)                         ThermoFisher Scientific                     Cat\# MA5-17673; RRID: AB_2539063
  CD328/Siglec-7-PerCP-Vio700 (REA214)               MILTENYI                                    Cat\# 130-100-979; RRID: AB_2657543
  CD335/NKp46-PC5 (BAB281)                           Beckman Coulter                             Cat\# A66904
  CD335/NKp46-PC7 (BAB281)                           Beckman Coulter                             Cat\# B38703
  CD335/NKp46-PE (BAB281)                            Beckman Coulter                             Cat\# IM3711; RRID: AB_1575960
  CD337/NKp30-BV605 (p30-15)                         BD Biosciences                              Cat\# 563384; RRID: AB_2738170
  DAP12-Alexa Fluor488 (406288)                      NOVUS BIOLOGICALS                           Cat\# IC5240G
  EOMES-PerCP-eFluor710 (WD1928)                     ThermoFisher Scientific                     Cat\# 46-4877-42; RRID: AB_2573759
  FcR (γ-chain)-FITC (rabbit polyclonal)             Millipore Milli-Mark                        Cat\# FCABS400F; RRID: AB_11203492
  FcR (γ-chain)-Alexa Fluor700 (rabbit polyclonal)   Millipore Milli-Mark                        Conjugated in-house
  Granzyme B-Alexa Fluor700 (GB11)                   BD Biosciences                              Cat\# 560213; RRID: AB_1645453
  HELIOS-e450 (22F6)                                 ThermoFisher Scientific                     Cat\# 48-9883-42; RRID: AB_2574136
  HELIOS-PE E610 (22F6)                              ThermoFisher Scientific                     Cat\# 61-9883-42; RRID: AB_2574682
  HLA-DR-ECD (HLA-DR)                                Beckman Coulter                             Cat\# IM3636; RRID: AB_10643231
  IFN-γ-PE-Cy7 (B27)                                 BD Biosciences                              Cat\# 560924; RRID: AB_2033978
  IFN-γ-BV711 (B27)                                  BD Biosciences                              Cat\# 564039; RRID: AB_2738557
  MIP1-β-APC-H7 (D21-1351)                           BD Biosciences                              Cat\# 561280; RRID: AB_10611567
  Perforin-FITC (pf344)                              mABTech                                     Cat\# 3465-7; RRID: AB_1925742
  Perforin-Pacific Blue (dG9)                        BioLegend                                   Cat\# 308118; RRID: AB_10899565
  phospho-CD3ζ-Alexa Fluor647 (K25-407.69)           BD Biosciences                              Cat\# 558489; RRID: AB_647152
  phospho-Syk-Pacific Blue (rabbit polyclonal)       Cell Signaling Technology                   Cat\# 12967
  phospho-Syk/ZAP70-PE-Cy7 (17A/P-ZAP70)             BD Biosciences                              Cat\# 561458; RRID: AB_10696417
  Syk-PE (4D10.1)                                    ThermoFisher Scientific                     Cat\# 17-6696-42; RRID: AB_10714836
  TNF-α-BV650 (Mab11)                                BD Biosciences                              Cat\# 563418; RRID: AB_2738194
  ZAP70-Pacific Blue (1E7.2)                         ThermoFisher Scientific                     Cat\# MHZAP7004-4; RRID: AB_2539777
  Critical Commercial Reagents                                                                   
  Fix Buffer I phosflow^™^                           BD Biosciences                              Cat\# 557870
  Perm Buffer III phosflow^™^                        BD Biosciences                              Cat\# 558050
  Fixation Medium A                                  ThermoFisher Scientific                     Cat\# GAS001S100
  Permeabilization Medium B                          ThermoFisher Scientific                     Cat\# GAS002S100
  Experimental Models: Organisms                                                                 
  *Macaca mulatta*                                   Tulane National Primate Research Center     N/A
  *Macaca mulatta*                                   Alphagenesis Inc.                           N/A
  Software                                                                                       
  Graphpad Prism 7                                   GraphPad Software                           <https://www.graphpad.com/scientific-software/prism/>
  FacsDiva                                           BD Biosciences                              <http://www.bdbiosciences.com/us/instruments/clinical/software/flowcytometry-acquisition/bd-facsdiva-software/m/333333/overview>
  FlowJo                                             FlowJo LLC                                  <https://www.flowjo.com/solutions/flowio/downloads>

###### Highlights

-   Δg NK cell expansion and acquisition of function are driven by concurrent CMV infection

-   Δg NK cells are distributed systemically but have the propensity to migrate to mucosal sites

-   Δg NK cells abandon γ-chain/Syk signaling in lieu of the atypical CD3ζ-Zap70 signaling pathway

-   SIV infection subverts Δg NK cells by suppressing CD16-mediated CD3ζ-ZAP70 signaling
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